PSC Literature Logo
  Primary Sclerosing Cholangitis Literature  
 
Home Page
 
FAQ
 
PSC Partners
 
www Resources
 
Scientific Literature
 
Genes
 
Pathways
 
Miscellaneous
 
PubMed Search
 
PubChem Search
 
Scirus Search
 
Site Statistics
 

Frequently Asked Questions (FAQ)

  • Can you recommend a short article describing Primary Sclerosing Cholangitis (PSC)?
  • Can you recommend a well-illustrated article describing Primary Sclerosing Cholangitis (PSC)?
  • Can you recommend a good article describing what abnormal liver test results mean?
  • Can you recommend an inspiring book?
  • How do I join a PSC support group?
  • How can I respond to my relatives and friends who offer their help?
      You can ask them to donate to our foundation, "PSC Partners Seeking a Cure", by mailing them a note card and a short letter with your personal information. We have included a couple of sample letters that you may wish to use.
  • How do I calculate a "Mayo Risk Score"?
  • How do I calculate a "Model for End-Stage Liver Disease (MELD) Score"?
      A MELD score calculator and associated documentation is available at the United Network for Organ Sharing (UNOS) website. This calculation is typically used for patients older that 12 years of age, and is employed for liver allocation. The numerical score (which ranges from 6 to 40) is based on total bilirubin, international normalized ratio (INR), and serum creatinine. It attempts to quantify a patient's risk of dying while waiting for a liver transplant. The higher the score, the higher the risk of death. Please also visit our Model for End-Stage Liver Disease (MELD) Score Calculator to view the formula used to calculate MELD. An alternative calculation called PELD (Pediatric End-Stage Liver Disease) is used for patients younger than 12 and is based on bilirubin, INR, albumin, growth failure, and age when listed for transplant.
  • How do I calculate my medication dose in terms of mg per kg per day (mg/kg/d)?
      To calculate your medication dose in terms of mg per kg per day (mg/kg/d) please visit our Medication Dose Calculator web page. You will need to know your weight in pounds (lb), and your daily dose of medication in mg.
  • What is a cholangitis attack, and what are the symptoms?
      Cholangitis is an inflammation of the bile duct system that is usually related to a bacterial infection. It may occur as a result of blockage and/or inflammation of the bile ducts. Bile is normally sterile but can become infected with bacteria when obstruction of the bile ducts occurs. Symptoms of cholangitis can include any combination of the following:
      • pain in the right upper quarter of the abdomen (pain may also occur in the chest, in the upper back, or the right shoulder)
      • tenderness in the upper abdomen
      • nausea and vomiting
      • belching
      • fever
      • chills
      • jaundice - yellowing of the skin and eyes
      • low blood pressure
      • lethargy
      • decreased level of alertness
      • itching
      • pale stools
      • dark urine
      If a fever and chills occur, then it is likely that a bacterial infection is present, and medical attention should be sought immediately. Antibiotics can be administered to control the infection. For further information on this potentially life-threatening complication of primary sclerosing cholangitis, please consult the following articles:
  • What is pruritus?
  • What is ursodiol?
      Ursodiol (also known as ursodeoxycholic acid, and sometimes abbreviated "URSO" or "UDCA") is a bile acid originally identified in bear bile. The name originates from the name of the bear family, Ursidae. Ursodiol was first used in Western medicine to dissolve cholesterol gallstones, but has more recently been used to treat a number of cholestatic liver diseases, including primary biliary cirrhosis (PBC), and liver disease associated with cystic fibrosis. It is thought to protect liver cells against certain toxic bile acids that accumulate in the liver in chronic cholestatic liver diseases. In PBC, ursodiol treatment has been shown to improve liver biochemistry and delay disease progression and time to liver transplantation. In primary sclerosing cholangitis (PSC), high-dose ursodiol has been shown to improve liver biochemistry, but studies are still in progress to determine if it delays disease progression and prolongs time to liver transplantation. There is growing evidence that ursodiol may protect against colon cancer and cholangiocarcinoma. Trade names for ursodiol include "Actigall" (typically available as 300 mg capsules) and "URSO" (typically available as 250 mg tablets). Side effects of this medication are described in an article from Jackson Gastroenterology: "Ursodiol". Please note that in some patients ursodiol can increase itching! For a detailed article on ursodiol, please consult: "Ursodiol for Hepatobiliary Disorders" (Annals of Internal Medicine).
  • Where can I find information on how to let family and friends donate funds to promote research, education and support for love-ones afflicted with PSC?

Google
www psc-literature.org

David and Judy Rhodes
Last Update: 04/29/08